第一作者（包含并列第一, IF>10）：
1.Tao Zuo#, Qin Liu#, Fen Zhang# et al. Depicting SARS-CoV-2 fecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut (2020). (影响因子: 19.819, 杂志排名: 1/145 in gastroenterology)
2.Tao Zuo#, Yang Sun#, Yating Wan et al. Human Gut DNA Virome Variations across Geography, Ethnicity, and Urbanisation. Cell Host & Microbe (2020). (CELL子刊，影响因子: 15.923, 杂志排名: 4/158 in microbiology)
3.Tao Zuo#, Fen Zhang# et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology (2020). https://doi.org/10.1053/j.gastro.2020.05.048. (影响因子: 17.373, 杂志排名: 2/145 in gastroenterology)
4.Tao Zuo#, Hui Zhan# et al. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalisation until Discharge. Gastroenterology (2020). (影响因子: 17.373, 杂志排名: 2/145 in gastroenterology)
5.Tao Zuo, Siew C Ng et al. Gut mucosal virome alterations in ulcerative colitis. Gut (2019): gutjnl-2018. (影响因子: 19.819, 杂志排名: 1/145 in gastroenterology)
6.Tao Zuo, Siew C Ng. Authors response: giant oversights in the human gut virome. Gut, gutjnl-2019. (2019) (影响因子: 19.819, 杂志排名: 1/145 in gastroenterology)
7.Tao Zuo, Michael A. Kamm, Jean-Frédéric Colombel, Siew C Ng. Urbanization and the gut microbiota in health and inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology, 2018, 1. doi:10.1038/s41575-018-0003-z. (影响因子: 29.848, 杂志排名: 3/145 in gastroenterology)
8.Tao Zuo, Wong S H, Lam K, Siew C Ng et al. Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome. Gut, 2018, 67(4):634-643. (影响因子: 19.819, 杂志排名: 1/145 in gastroenterology)
9.Tao Zuo, Sunny H Wong, Siew C Ng et al. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection. Nature Communications, 2018, doi: 10.1038/s41467-018-06103-6. (影响因子: 12.121, 杂志排名: 3/145 in Multidisplinary)
10.Fen Zhang#, Tao Zuo#, Yun Kit Yeoh#, et al. Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease.Nature Communications (影响因子: 12.121, 并列第一).
11.Yang Sun#, Tao Zuo#, et al. Population-level configurations of gut mycobiome across six ethnicities in urban and rural China.Gastroenterolgoy (影响因子: 17.373, , 杂志排名: 2/145 in gastroenterology, 并列第一)
12.Yun Kit Yeoh#, Tao Zuo#, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in COVID-19 patients. Gut (2020). (影响因子: 19.819, 杂志排名: 1/145 in gastroenterology, 并列第一)
13.Tao Zuo#, Liu Q#, Zhang F#, et al. Temporal Landscape of Human Gut virome in SARS-CoV-2 infection and severity. Microbiome. (2021). In press. (共同第一，影响因子: 11.607, 杂志排名: 3/128 in Microbiology (medical))
14. Tao Zuo, Yun Kit Yeoh, Siew C Ng. Reply: The New Foe and Old Friends: Are We Ready for Microbiota-based Therapeutics in Treating COVID-19 Patients? Gastroenterolgoy (2021). (影响因子: 17.373, , 杂志排名: 2/145 in gastroenterology)
第一作者（及并列第一, IF<10）：
15.Tao Zuo, and Siew C. Ng. The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Frontiers in microbiology 9 (2018). (影响因子: 4.235, 杂志排名: 27/129 in gastroenterology)
16.Wu WKK^, Sun R^, Zuo T^, Tian Y^, Zheng Z, Ho J, Wu JCY, Chan FKL, Chan MTV, Yu J, Wong SH*, Wang MH*, Ng SC*. A novel susceptibility locus in MST1 and gene-gene interaction network for Crohn's disease in the Chinese. J Cell Mol Med, 2018, 22(4), 2368-2377. doi: 10.1111/jcmm.13530. (Co-first author) (并列第一，影响因子:4.658, 杂志排名: 38/175)
17.Tao Zuo, R Zhao, S LU, N Zhang, Q Zhang, C Xue. Novel dietary polysaccharide SIP promotes intestinal secretory immunoglobulin A secretion in mice under chemotherapy. Journal of functional foods. 2017,37, 379–389. (影响因子: 3.701, 杂志排名: 41/327 in Food Science)
18.Zuo Tao, Zhang Na, Zhang Qi, et al. Transportation of squid ink polysaccharide SIP through intestinal epithelial cells and its utilization in the gastrointestinal tract. Journal of Functional Foods, 2016, 22: 408-416. (影响因子: 3.701, 杂志排名: 41/327 in Food Science)
19.Tao Zuo, Lu Cao, Xuemin Li, Qi Zhang, Changhu Xue, Qingjuan Tang. The squid ink polysaccharides protect tight junctions and adherens junctions from chemotherapeutic injury in the small intestinal epithelium of mice. Nutrition and Cancer. 2015, 67.2:364-371. (影响因子: 2.322, 杂志排名: 63/128 in Nutrition and Dietetics)
20.Tao Zuo, Xuemin Li, Yaoguang Chang, Gaofei Duan, Long Yu, Rong Zheng, Changhu Xue, Qingjuan Tang. Dietary fucoidan of Acaudina molpadioides and its enzymatic degraded fragments could prevent intestinal mucositis induced by chemotherapy in mice. Food and Function. 2015,6, 415-422. (影响因子: 3.701, No. of citation: 5, 杂志排名: 41/327 in Food Science) (影响因子: 4.171, 杂志排名: 36/327 in Food Science)
21.Tao Zuo, Xinjia He, Lu Cao, Changhu Xue, Qingjuan Tang. Dietary polysaccharide from Ommastrephes bartrami prevents chemotherapeutic mucositis by promoting the genes expression of antimicrobial peptides in paneth cells. Journal of functional foods. 2015, 12:530-539. (影响因子: 3.701, 杂志排名: 41/327 in Food Science)
22.Tao Zuo, Lu Cao, Xuemin Li, Changhu Xue, Qingjuan Tang*. Dietary squid ink polysaccharide induces goblet cells to protect small intestine from chemotherapy induced injury. Food and function, 2015, 6(3): 981-986. (影响因子: 4.171, 杂志排名: 39/327 in Food Science)
23.Tao Zuo, Xianqi Feng, Na Zhang, Changhu Xue, Qing-Juan Tang*. Establishment of a functional secretory IgA transcytosis model system in vitro for functional food screening. J Applied Microbiology and Biotechnology. 2015, 6(3): 981-986. (影响因子: 3.670, 杂志排名: 41/327 in Food Science)
24.Tao Zuo, Lu Cao, Xianghong Sun, Xuemin Li, Juan Wu, Shangyun Lu, Changhu Xue, and Qing-Juan Tang*. Dietary Squid Ink Polysaccharide Could Enhance Siga Secretion in Chemotherapeutic Mice. Food and Function. 2014, 5(12): 3189-3196. (影响因子: 4.171, 杂志排名: 39/327 in Food Science)
25.Tao Zuo, Zhaojie Li, Yingchun Lv, Gaofei Duan, Chunxia Wang, Qingjuan Tang, Changhu Xue. Rapid identification of sea cucumber species with multiplex-PCR. Food control, 2012, 26(1):58-62. (影响因子: 4.258, 杂志排名: 18/327 in Food Science)
26.Tang, Qingjuan1, Tao Zuo1, Shangyun Lu, Juan Wu, Jianghua Wang, Rong Zheng, Shiguo Chen, and Changhu Xue*. Dietary Squid Ink Polysaccharides Ameliorated the Intestinal Microflora Dysfunction in Mice Undergoing Chemotherapy. Food and function, 2014, 5 (10):2529-35. (并列第一) (影响因子: 4.171, 杂志排名: 39/327 in Food Science)
通讯作者：
27.Zuo T*. Unveiling the gut virome in human health and diseases. Int J Clin Virol. 2018; 2: 001-003. (第一及通讯作者)
28.Tao Zuo*. The Changing Landscape of the Effect of food/diet on the gut Microbiota in Relation to Health and Disease. Nutrition and Food Toxicology, 2017, 2.1: 262-264. (第一及通讯作者)
29.Zhang N, Ju Z, Zuo T*. Time for food: the impact of diet on gut microbiota and human health[J]. Nutrition, 2018. (通讯作者，影响因子：3.639)
30.Shangyun Lu and Tao Zuo*. Effect of Food Additives on the Gut Microbiome in Relation to Human Health. Nutrition and Food Toxicology 2.5 (2018): 474-476. (通讯作者)
31.Fen Zhang, Tao Zuo*. From Gut Microbial Ecogroup to Precision Nutrition and Human Health. Austin J Nutr Metab. 2019; 6(2): 1070. (通讯作者)
32.Hui Zhan, Tao Zuo*. Frontiers in human mycobiome in health and disease. American Journal of Biomedical Science & Research. 2020 - 7(4). AJBSR.MS.ID.001170. DOI:10.34297/AJBSR.2020.07.001170. (通讯作者)
国际论坛演讲
1.Oral presentation: Digestive disease week, Chicago, USA; 2017
Microbiome & Microbial Diseases in the Gastrointestinal Tract, “Bacteriophage transfer during fecal microbiota transplantation is associated with treatment response in Clostridium difficile infection”
2.Oral presentation: Digestive disease week, Washington DC, USA; 2018
Distinguished microbiome plenary session, “Fecal microbiota transplantation alters the gut mycobiome (fungome) which correlates with treatment outcome in Clostridium difficile infections”
3.Invited speaker: Microiome Science Days, Berchtesgaden, Germany; 2018
“Gut Fungi and Fecal microbiota transplantation”
4.Oral presentation: Digestive disease week, San Diego, USA; 2019
IBD: Microbiome session, “Increased bacteriophage abundance and loss of viral-bacterial interactions in the mucosa of Ulcerative Colitis: Key to Pathogenesis?”
5.Oral presentation: Digestive disease week, San Diego, USA; 2019
Research Forum, Committee Sponsored Symposium; Presentation of Best of AGA (American Gastroenterological Association) at DDW in Chinese
6.Oral presentation: Digestive disease week, Chicago, USA; 2020
Dark Matter: Nonbacterial Kingdoms of the Gut Microbiome, “The human gut virome is geography and ethnicity specific: population-based viral metagenomics across six ethnicities in rural and urban China”
7.Invited speaker: Avison Symposium, Seoul, Korea; 2020
“Microbiome in Human Health”
8.Invited speaker: Targeting Microbiota 2021 Virtual Congress: October 22-23, 2021, France. International Society of Microbiota.
Many aspects of the Gut microbiome in Patients With COVID-19.
